L.M. Fabbri (Modena, Italy), T. Jacinto (Senhora Da Hora, Portugal), K.F. Rabe (Großhansdorf, Germany), E. F. M. Wouters (Maastricht, The Netherlands)
LATE-BREAKING ABSTRACT: Elevated cardiovascular risk as measured by QRISK2 score in patients hospitalized for acute COPD exacerbation versus stable COPD outpatients
E. Pagliaroli, D. Mohan, V. Padmanaban, S. Elkin, P. Palange, M. Polkey (Rome, Italy; London, United Kingdom)
|   |
LATE-BREAKING ABSTRACT: Risk factors for osteoporosis in patients with COPD: 2008-2010 Korean NHANES
S. J. Lee, K. A. Kong, Y. J. Ryu, J. H. Lee, J. H. Chang (Seoul, Republic Of Korea)
| |
Changes in the level of melatonin in patients with varying degrees of severity of chronic obstructive pulmonary disease in conjunction with gastroesophageal reflux disease
V. Kamenir, D. Kalashnyk, O. Korotchenko (Kharkov, Ukraine)
| |
The effectiveness of anti-inflammatory therapy for chronic obstructive pulmonary disease complicated by ischemic heart disease (new medication - new opportunities)
P. Gerych, R. Yatsyshyn (Ivano-Frankivsk, Ukraine)
| |
Comorbidities impair physical activity in COPD irrespective of airflow limitation
C. Clarenbach, N. Sievi, O. Senn, T. Brack, M. Brutsche, M. Frey, S. Irani, J. Leuppi, R. Thurnheer, D. Franzen, M. Kohler (Zurich, Glarus, St. Gallen, Barmelweid, Aarau, Liestal, Münsterlingen, Switzerland)
| |
Characteristics of pulmonary function of COPD with and without arterial pulmonary hypertension
K. Yazaki, N. Kamada, K. Asakura, R. Oba, E. Sato, M. Sato, T. Sato, K. Kikuchi (Yuri-Honjo, Akita, Japan)
| |
Dynamic changes in quadriceps strength and 6 minute walk distance during COPD exacerbations in the COPDMAP consortium
B. Barker, U. Kolsum, V. Gupta, K. Edwards, M. Shelley, J. Finch, D. Singh, C. Brightling, M. Steiner (Leicester, Manchester, United Kingdom)
| |
Inter-relationship of different types of respiratory symptoms in COPD
P. W. Jones, M. Miravitlles, F. Chuecos, E. Garcia Gil, R. Lamarca (London, United Kingdom; Barcelona, Spain)
| |
COPD and depression: Prevalence and interaction
A. Dovgan, Y. Mostovoy, T. Konstantynovych, H. Demchuk (Vinnytsia, Ukraine)
| |
Quality of life (QL) depending on psychological disorders (PD) of patients with chronic obstructive pulmonary disease (COPD)
K. Cicirello-Konstantynovych, Y. Mostovoy, T. Konstantynovych, A. Dovgan (Vinnytsia, Ukraine)
| |
Nutritional status in chronic obstructive pulmonary disease
S. Habibech, H. Kwas, I. Zendah, A. Aymen, A. Khattab, I. Khouaja, H. Ghedira (Ariana, Tunisia)
| |
Effect of basic therapy of chronic obstructive pulmonary disease on the clinical course of acute myocardial infarction
Y. Mostovoy, L. Rasputina, V. Cherbak, T. C?briy, A. Rasputina, A. Vachuk, H. Demchuk (Vinnytsia, Ukraine)
| |
Peripheral neuropathy in chronic obstructive pulmonary disease
W. Feki, W. Ketata, I. Hammami, N. Bahloul, W. K. Rekik, H. Ayadi, S. Kammoun (SFAX, Tunisia)
| |
Acute exacerbations of chronic obstructive pulmonary disease: Is it acute exacerbations of chronic cardiopulmonary disease?
A. Sadigov, F. Abdullaev, S. Aliyev (Baku, Azerbaijan)
| |
Additional therapy of COPD patients with respiratory muscles dysfunction
O. Myronenko (Dnipropetrovsk, Ukraine)
| |
Role of activated complement in COPD exacerbation recovery
A. Mackay, J. P. Westwood, G. Donaldson, R. Singh, S. Machin, M. Scully, J. Wedzicha (London, United Kingdom)
| |
Markers of bone metabolism in men with chronic obstructive pulmonary disease (COPD) aged 40-70 years
S. Lemiasheuskaya (Minsk, Belarus)
| |
Stable state MR-proadrenomedullin level in COPD patients; a validation study
M. Zuur-Telgen, P. vanderValk, J. van der Palen, H. Kerstjens, M. Brusse-Keizer (Enschede, Groningen, Netherlands)
| |